IL2 and melanoma: This type of autocrine IL-2 circuit also shows similar dramatic therapeutic improvement in treating a different type of immune-excluded solid tumor – B16-F10 OVA intradermal melanoma tumors, treated with OT-1 TCR expressing T cells (Fig 2E, S7C).